Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverDRMA
HealthcareNCMUSD

Dermata Therapeutics, Inc.

$00123456789.0012345678900123456789+4.8%
52w low (est.) $1.06$1.65 52w high (est.)
Market data · updated 4m ago
Market data
Market cap
USD5.31M
52w range
USD1.10 - USD7.33
Beta
0.67
Sector
Healthcare
Data quality
67/100
Valuation
DCF fair value
USD1.59
Margin of safety
+20.5%
Quality & efficiency
Moat score
5/100
Return on equity
-103.6%
Growth & analysts
Analyst target
USD4.00
Target upside
+203.0%
Analysts
1
Run the 10-point checklist before you buy How these numbers are made

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Valuation

ValueGrowthProfitHealthIncome37QUALITY
Overall Rating
38
Reduce
Reduce

Derived from filed metrics · Moderate confidence (67% of the inputs available)

Moat Score5
DCF Intrinsic Value
USD1.59+20.5% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD5.31M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
-103.6%
Debt / Equity
0.00
Beta
0.67
Beaten Down
vs Healthcare sector:Moat 5 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · DRMA